Is Apollomics Stock a Good Investment?

Apollomics Investment Advice

APLM

To provide specific investment advice or recommendations on Apollomics Class A stock, we recommend investors consider the following general factors when evaluating Apollomics Class A. This will help you to make an informed decision on whether to include Apollomics in one of your diversified portfolios:

Examine Apollomics' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Apollomics' leadership team and their track record. Good management can help Apollomics navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Biotechnology space and any emerging trends that could impact Apollomics' business and its evolving consumer preferences.
Compare Apollomics' performance and market position to its competitors. Analyze how Apollomics is positioned in terms of product offerings, innovation, and market share.
Check if Apollomics pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Apollomics' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Apollomics Class A stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Apollomics Class A is a good investment.

Sell

Buy

Strong Sell

We provide trade advice to complement the prevailing expert consensus on Apollomics Class A. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Apollomics is not overpriced, please confirm all Apollomics Class A fundamentals, including its cash flow from operations, and the relationship between the revenue and beta . Given that Apollomics Class A has a shares owned by institutions of 2.08 %, we suggest you to validate Apollomics Class A market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Market Performance	Weak	Details
Volatility	Risky	Details
Hype Condition	Over hyped	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Very High	Details
Economic Sensitivity	Follows the market closely	Details
Investor Sentiment	Alarmed	Details
Analyst Consensus	Buy	Details
Financial Strenth (F Score)	Healthy	Details
Financial Leverage	Inapplicable	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine Apollomics Stock

Researching Apollomics' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 47.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.47. Some equities with similar Price to Book (P/B) outperform the market in the long run. Apollomics Class A recorded a loss per share of 0.15. The entity had not issued any dividends in recent years.

To determine if Apollomics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Apollomics' research are outlined below:

	Apollomics Class A had very high historical volatility over the last 90 days
	Apollomics Class A has a very high chance of going through financial distress in the upcoming years
	The company reported the previous year's revenue of 821 K. Net Loss for the year was (172.59 M) with profit before overhead, payroll, taxes, and interest of 0.
	Apollomics generates negative cash flow from operations
	About 47.0% of the company shares are held by company insiders

Apollomics Quarterly Accounts Payable

947,000

Apollomics uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Apollomics Class A. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Apollomics' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	26th of April 2024 Upcoming Quarterly Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	26th of April 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Apollomics' market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.52 M.

Market Cap

5.74 Billion

Apollomics' profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	(4.89)	(4.64)
Return On Capital Employed	(1.51)	(1.58)
Return On Assets	(3.58)	(3.40)
Return On Equity	(4.81)	(4.57)

Determining Apollomics' profitability involves analyzing its financial statements and using various financial metrics to determine if Apollomics is a good buy. For example, gross profit margin measures Apollomics' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Apollomics' profitability and make more informed investment decisions.

Evaluate Apollomics' management efficiency

Apollomics Class A has return on total asset (ROA) of (0.6274) % which means that it has lost $0.6274 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4931) %, meaning that it created substantial loss on money invested by shareholders. Apollomics' management efficiency ratios could be used to measure how well Apollomics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 31st of January 2025, Return On Tangible Assets is likely to grow to -4.64. In addition to that, Return On Capital Employed is likely to drop to -1.58. At this time, Apollomics' Total Assets are very stable compared to the past year. As of the 31st of January 2025, Non Current Assets Total is likely to grow to about 19.9 M, while Other Current Assets are likely to drop about 1.3 M.

	Last Reported	Projected for Next Year
Book Value Per Share	0.64	0.67
Tangible Book Value Per Share	0.41	0.43
Enterprise Value Over EBITDA	(37.48)	(39.35)
Price Book Value Ratio	156.70	164.54
Enterprise Value Multiple	(37.48)	(39.35)
Price Fair Value	156.70	164.54
Enterprise Value	6.4 B	5.7 B

The decision-making processes within Apollomics are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.

Beta

1.212

Basic technical analysis of Apollomics Stock

As of the 31st of January, Apollomics shows the Downside Deviation of 9.25, risk adjusted performance of 0.015, and Mean Deviation of 7.61. Apollomics Class A technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Apollomics Class A coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Apollomics Class A is priced correctly, providing market reflects its regular price of 8.5 per share. Given that Apollomics has jensen alpha of 0.0366, we suggest you to validate Apollomics Class A's prevailing market performance to make sure the company can sustain itself at a future point.

Apollomics' insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Apollomics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Apollomics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Apollomics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Yungfong Song over six months ago

Conversion by Yungfong Song of 2482500 shares of Apollomics

Understand Apollomics' technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Apollomics' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.015
	Market Risk Adjusted Performance	0.1591
	Mean Deviation	7.61
	Semi Deviation	8.77
	Downside Deviation	9.25
	Coefficient Of Variation	15134.65
	Standard Deviation	15.48
	Variance	239.57
	Information Ratio	2.0E-4
	Jensen Alpha	0.0366
	Total Risk Alpha	(1.57)
	Sortino Ratio	3.0E-4
	Treynor Ratio	0.1491
	Maximum Drawdown	134.75
	Value At Risk	(15.46)
	Potential Upside	18.55
	Downside Variance	85.51
	Semi Variance	76.85
	Expected Short fall	(10.15)
	Skewness	4.46
	Kurtosis	29.4

	Risk Adjusted Performance	0.015
	Market Risk Adjusted Performance	0.1591
	Mean Deviation	7.61
	Semi Deviation	8.77
	Downside Deviation	9.25
	Coefficient Of Variation	15134.65
	Standard Deviation	15.48
	Variance	239.57
	Information Ratio	2.0E-4
	Jensen Alpha	0.0366
	Total Risk Alpha	(1.57)
	Sortino Ratio	3.0E-4
	Treynor Ratio	0.1491
	Maximum Drawdown	134.75
	Value At Risk	(15.46)
	Potential Upside	18.55
	Downside Variance	85.51
	Semi Variance	76.85
	Expected Short fall	(10.15)
	Skewness	4.46
	Kurtosis	29.4

Consider Apollomics' intraday indicators

Apollomics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Apollomics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	0.0484
	Daily Balance Of Power	(1.02)
	Rate Of Daily Change	0.95
	Day Median Price	8.66
	Day Typical Price	8.61
	Market Facilitation Index	0.43
	Price Action Indicator	(0.38)
	Period Momentum Indicator	(0.44)

Apollomics Corporate Filings

	10th of January 2025 Other Reports	View Verify
6K	20th of December 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.	View Verify
F3	15th of August 2024 An amendment to the original Schedule 13D filing	View Verify
13A	30th of May 2024 An amended filing to the original Schedule 13G	View Verify

Apollomics time-series forecasting models is one of many Apollomics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Apollomics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Apollomics Stock media impact

Far too much social signal, news, headlines, and media speculation about Apollomics that are available to investors today. That information is available publicly through Apollomics media outlets and privately through word of mouth or via Apollomics internal channels. However, regardless of the origin, that massive amount of Apollomics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Apollomics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Apollomics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Apollomics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Apollomics alpha.

Apollomics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Apollomics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Apollomics Corporate Management

Matthew Plunkett	Chief Officer	Profile
Chinglin Lai	Senior Management	Profile
KinHung MD	Chief Officer	Profile
Lijuan Wang	Chief China	Profile

Already Invested in Apollomics Class A?

The danger of trading Apollomics Class A is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Apollomics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Apollomics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Apollomics Class A is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

When determining whether Apollomics Class A is a strong investment it is important to analyze Apollomics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Apollomics' future performance. For an informed investment choice regarding Apollomics Stock, refer to the following important reports: